IHE
iShares U.S. Pharmaceuticals ETF

Down$150.90
$-3.00
(-1.95%)
As of 4:57:07 PM EDT | 11/14/18  |  Market Closed

IHE Trading Data

Open

$153.44

Low Price

$150.2

High Price

$153.44

Previous Last Price

$153.9

Bid Size

$150 X 600

Ask Size

$154.1 X 600

IHE Portfolio Data

AUM

$418,527,000

Shares

2,700

PE Ratio

21.56

Price / Book Ratio

3.43

Expense Ratio

0.43

Net Asset Value

$155.01

Volume

Volume

13,790

Avg. Volume (YDT)

18,057

Dollar Volume

$1,169,807

Weekly Avg. Volume

9,438

Monthly Avg. Volume

17,750

Quarterly Avg. Volume

19,809

IHE Fund Description

The iShares U.S. Pharmaceuticals ETF seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector. The Fund seeks investment results that correspond to the price and yield of the Dow Jones U.S. Select Pharmaceuticals Index.

IHE Chart

IHE Summary

Fund Family

BlackRock iShares

Tracks This Index

iShares U.S. Pharmaceuticals ETF

Inception Date

2006-05-01

Asset Class

Equity

Asset Class Size

Biotech

IHE Classification

Region (General)

North America

Region (Specific)

US

Sector

Health Care

Equity Index

Leveraged Family

IHE Holdings

Top 10 Holdings

JOHNSON & JOHNSON (JNJ)
11.44%
PFIZER INC (PFE)
9.77%
MERCK & CO INC (MRK)
8.95%
ELI LILLY (LLY)
6.98%
BRISTOL MYERS SQUIBB (BMY)
5.77%
ZOETIS INC CLASS A (ZTS)
5.05%
ALLERGAN (AGN)
4.69%
MYLAN NV (MYL)
3.39%
JAZZ PHARMACEUTICALS PLC (JAZZ)
2.35%
PERRIGO PLC (PRGO)
2.23%

Total IHE Holdings

Total Holdings: 50

JOHNSON & JOHNSON (JNJ)
11.44%
PFIZER INC (PFE)
9.77%
MERCK & CO INC (MRK)
8.95%
ELI LILLY (LLY)
6.98%
BRISTOL MYERS SQUIBB (BMY)
5.77%
ZOETIS INC CLASS A (ZTS)
5.05%
ALLERGAN (AGN)
4.69%
MYLAN NV (MYL)
3.39%
JAZZ PHARMACEUTICALS PLC (JAZZ)
2.35%
PERRIGO PLC (PRGO)
2.23%
CATALENT INC (CTLT)
1.97%
HORIZON PHARMA PLC (HZNP)
1.89%
MALLINCKRODT (MNK)
1.54%
PACIRA PHARMACEUTICALS INC (PCRX)
1.49%
PRESTIGE CONSUMER HEALTHCARE INC (PBH)
1.47%
ENDO INTERNATIONAL PLC (ENDP)
1.43%
VANDA PHARMACEUTICALS INC (VNDA)
1.39%
MYOKARDIA INC (MYOK)
1.36%
AMICUS THERAPEUTICS INC (FOLD)
1.33%
AERIE PHARMACEUTICALS INC (AERI)
1.23%
INNOVIVA INC (INVA)
1.21%
ZOGENIX INC (ZGNX)
1.21%
CORCEPT THERAPEUTICS INC (CORT)
1.17%
AMNEAL PHARMACEUTICALS INC CLASS A (AMRX)
1.14%
INTERSECT ENT INC (XENT)
1.13%
MADRIGAL PHARMACEUTICALS INC (MDGL)
1.11%
AMPHASTAR PHARMACEUTICALS INC (AMPH)
1.07%
THERAVANCE BIOPHARMA INC (TBPH)
1.06%
IRONWOOD PHARMA INC CLASS A (IRWD)
1.05%
MEDICINES (MDCO)
1.04%
SPECTRUM PHARMACEUTICALS INC (SPPI)
0.96%
INTRA CELLULAR THERAPIES INC (ITCI)
0.93%
THERAPEUTICSMD INC (TXMD)
0.92%
REATA PHARMACEUTICALS INC CLASS A (RETA)
0.92%
TESARO INC (TSRO)
0.91%
REVANCE THERAPEUTICS INC (RVNC)
0.91%
CYMABAY THERAPEUTICS INC (CBAY)
0.87%
PHIBRO ANIMAL HEALTH CORP CLASS A (PAHC)
0.87%
WAVE LIFE SCIENCES LTD (WVE)
0.82%
AMAG PHARMACEUTICALS INC (AMAG)
0.77%
DERMIRA INC (DERM)
0.74%
ACLARIS THERAPEUTICS INC (ACRS)
0.69%
ASSERTIO THERAPEUTICS INC (ASRT)
0.68%
ASSEMBLY BIOSCIENCES INC (ASMB)
0.63%
AKORN INC (AKRX)
0.59%
OMEROS CORP (OMER)
0.59%
SYNERGY PHARMACEUTICALS INC (SGYP)
0.16%
USD CASH
0.1%
BLK CSH FND TREASURY SL AGENCY
0.06%
iShares Dow Jones U.S. Pharmaceutical Index Fund ETF (IHE)
0%

IHE Technicals

Alpha

-8.63

Beta

1.07

Leverage

Long

Standard Deviation

7.47

IHE Dividends

Dividend Date

2018-09-26

Latest Dividend

0.396

Annual Dividend

1.79

Annual Dividend Rate

1.79

Annual Dividend Yield

1.15

IHE Performance

YTD Return

-2.25%

1 Year Return

1.06%

3 Year Return

-4.06%

5 Year Return

31.27%

10 Year Return

268.27%

IHE Related Articles

ETF Plays for a Divided Midterm Elections

ETF Plays for a Divided Midterm Elections

With a contentious midterms election season coming up, many anticipate a split government that could potentially impact the way ETF investors ride the markets ahead. Some expectations point to Democrats…

Pharmaceutical ETFs Could Maintain Their Momentum

Pharmaceutical ETFs Could Maintain Their Momentum

Pharmaceutical stocks and sector-related exchange traded funds have enjoyed a great summer and the rally may continue to have legs. Over the past three months, the PowerShares Dynamic Pharmaceuticals Portfolio…

July Could Be a Volatile Month for Pharma ETFs

July Could Be a Volatile Month for Pharma ETFs

Changing political winds and the seasonal period for drugmakers to hike their prices could trigger short-term volatility in pharmaceutical sector-related ETFs. The markets could put a spotlight on pharmaceutical stocks…

Get Lucky With 10 Saint Patrick’s Day ETFs

Get Lucky With 10 Saint Patrick’s Day ETFs

Well folks, it’s that special time of the year on Saturday: the green revolution, the grand day of Guinness, the celebration of corn beef hash, and of course – Saint Patrick’s…

Drug Makers, Pharma ETFs Face a Tough Earnings Season

Drug Makers, Pharma ETFs Face a Tough Earnings Season

The healthcare sector has been lackluster this earnings season, and without supporting factors such as price increases or increased mergers and acquisitions to bolster the segment, pharmaceutical exchange traded funds…